I am encouraged that Orbimed are still there and Amgens recent support. But strike while the iron is hot. We are some 18 monts down the road from the Abbvie payment and now appears dead in the water
So all Amgen has done is loan us money in return for devices...we still need to prove brass tacks ability to supply quality devices at a volume and price to actually make money....to do that we need more money in the meantime?
We need to get thru to Jan '17 before we get the option of trying to give Amgen another 15million worth of notes.
Remember Amgen have the right to take up to 20% of production off UNS and use their own CMO (paying us a royalty) If we continue to drop the ball i am betting compliance issues will mean Amgen can take a greater % and pay less (no?) royalties as they wont be gambling millions in production, resources and filings to be at the complete mercy of UNS management. They will be covered
Really, what the co. does in the month of August is critical...frankly if Orbimed believe in this product then they have played UNS management perfectly like your common crack dealer and now is the time they come in and do a CR for 40 million and end up with good chunk of ownership
Should have stayed at the pub...12% down
Oh, and given our new CEOs healthy bank that he is taking home from running this ship, wouldnt kill him to buy a measely 50,000-100,000 shares